# Neurocognitive Effects of Opiate Agonist Treatment

> **NCT01733693** · PHASE4 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 135 (actual)

## Conditions studied

- Opioid-Related Disorders
- HIV
- HIV Infections

## Interventions

- **DRUG:** Buprenorphine
- **DRUG:** Methadone

## Key facts

- **NCT ID:** NCT01733693
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2022-02-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733693, "Neurocognitive Effects of Opiate Agonist Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01733693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*